12/13/2021Nine Observations from A Busy Few Weeks Back at the Heart of the China...

12/10/2021Recent Executive Moves

12/9/2021Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to...

12/9/2021Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...

12/9/2021China Extends Crackdown of BMI Frauds for Another Year

12/8/2021CDE Issues the Technical Guidelines for Application of Biomarkers in C...

12/8/2021Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...

12/7/2021Sanofi Scores A Trademark Win in China

12/6/2021Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...

12/6/2021Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...

12/6/2021Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...

12/6/2021SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...

12/6/2021Fujifilm Irvine Scientific Establishes Innovation Center in China

12/6/2021Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...

12/6/2021Maximizing China Access for Innovative Therapies (PharmExec)

12/5/2021Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...

12/3/2021BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...

12/3/2021Recent Executive Moves

12/2/2021NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...

12/2/2021WuXi STA and Coherent Biopharma Forms Strategic Partnership 

12/2/2021NHSA and MOHRSS Officially Issue the 2021 NRDL, Adding 74 and Removing...

12/1/2021Innovent and Ascentage Granted NMPA Approval for China's First 3rd Ge...

12/1/2021Genetron and AstraZeneca China Enter Co-Development Agreement for MR...

12/1/2021Novo Nordisk, Sanofi and Eli Lilly Cut Insulin Prices and Lose Share i...

11/30/2021NMPA Issues the Dossier Requirements for Import and Export Permit of N...

11/30/2021NMPA Announces Package Insert Revision of Glycerol Fructose and Sodium...

11/30/2021JPO Releases Final Tender Outcome of the 6th VBP

11/30/2021Jemincare Licenses Kras Inhibitor JMKX1899 to HUYABIO 

11/30/2021Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...

11/30/2021Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

Page:80/361 Total number of articles:10807: [First][<<] [78] [79] [80] [81] [82] [>>] [End]